Details of Protein
General Information of Protein (ID: PRT00576) | |||||
---|---|---|---|---|---|
Name | Solute carrier family 17 member 9 (SLC17A9) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Slc17a9
|
||||
Gene Name | Slc17a9 | Gene ID | |||
UniProt ID | |||||
Family | Sodium/anion cotransporter (SAC) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MPSQRSSLMQPIPEETRKTPSAAAEDTRWSRPECQAWTGILLLGTCLLYCARVTMPVCTV
AMSQDFGWNKKEAGIVLSSFFWGYCLTQVVGGHLGDRIGGEKVILLSASAWGFITVTTPL LAHLGSGHLAFLTFSRILTGLLQGVYFPALTSLLSQKVQESERAFTYSTVGAGSQVGTLV TGGVGSVLLDQCGWQSVFYFSGGLTLLWAYYVYRYLLNEKDLVLALGFLAQGLPVTKPSK VPWRQLFRKASVWAAICSQLCSACSFFILLSWLPTFFKETFPNSKGWVFNVVPWMLAIPA SLFSGFISDRLISQGYRVITVRKFMQVMGLGLSSIFALCLGHTTSFLKAMIFASASIGFQ TFNHSGISVNIQDLAPSCAGFLFGVANTAGALAGVVGVCLSGYLIETTGSWTCVFHLVAI ISNLGLGTFLVFGKAQRVDLVPTHEDL |
||||
Function | Involved in vesicular storage and exocytosis of ATP. May accumulate ATP and other nucleotides in secretory vesicles such as adrenal chromaffin granules and synaptic vesicles. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
ATP | Click to Show/Hide the Full List of Regulating Pair(s): 3 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockdown (siRNA) of Slc17a9 | |||||
Induced Change | ATP concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Adrenomedullary hyperfunction [ICD-11: 5A75] | |||||
Details | It is reported that knockdown of Slc17a9 leads to the decrease of ATP levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockdown (shRNA) of Slc17a9 | |||||
Induced Change | ATP concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of Slc17a9 leads to the decrease of ATP levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexpression of Slc17a9 | |||||
Induced Change | ATP concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Slc17a9 leads to the increase of ATP levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.